Safety aspects of oral poliovirus vaccine campaigns.
Hovi
T
T
National Public Health Institute, Helsinki, Finland.
D000328:Adult; D002675:Child, Preschool; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D007223:Infant; D011051:Poliomyelitis / Q000517:prevention & control / Q000635:transmission; D017955:Poliovirus / Q000302:isolation & purification; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects* / Q000592:standards; D011129:Polyradiculoneuropathy / Q000453:epidemiology / Q000209:etiology; D011247:Pregnancy; D012449:Safety; D014611:Vaccination / Q000009:adverse effects / Q000592:standards
D011055:Poliovirus Vaccine, Oral